SHAWN FURST, D.O.

D.O.

Physical Medicine & Rehabilitation Physician

NPI: 1154578565IndividualAccepts Medicare

Specialties, Licenses & Credentials

Physical Medicine & Rehabilitation PhysicianPrimary

Physical Medicine & Rehabilitation

Code: 208100000X

2008018701(MO)8206969-1204(UT)20A 12926(CA)

CMS Specialties

PrimaryPHYSICAL MEDICINE AND REHABILITATION

Education

OTHER

Class of 2008

Research & Publications (20)

My experiences. From sound stage to end-stage... Tinseltown learns about kidney failure.

PMID 17722859·Nephrol News Issues·2007

8-other

TRH and TRH-like peptide expression in rat following episodic or continuous corticosterone.

PMID 18657370·Psychoneuroendocrinology·2008

4-observational

Enhancing brain adenosine signaling with the nucleoside transport blocker NBTI (S-(4-nitrobenzyl)-6-theoinosine) mimics the effects of inescapable shock on later shuttle-escape performance in rats.

PMID 19045943·Behav Neurosci·2008

7-preclinical

Employee resistance to organizational change: managerial influence tactics and leader-member exchange.

PMID 18361644·J Appl Psychol·2008

8-other

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.

PMID 18679370·Bone Marrow Transplant·2008

4-observational

DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.

PMID 17845912·Brain Res Bull·2007

7-preclinical

Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (+/-) mice and syrian hamster embryo (SHE) assay.

PMID 16373391·Toxicol Sci·2006

7-preclinical

Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime.

PMID 16861108·Brain Res Bull·2006

7-preclinical

Screening New Drugs for Immunotoxic Potential: II. Assessment of the Effects of Selective and Nonselective COX-2 Inhibitors on Complement Activation, Superoxide Anion Production and Leukocyte Chemotaxis and Migration Through Endothelial Cells.

PMID 18958662·J Immunotoxicol·2005

8-other

Screening new drugs for immunotoxic potential: III. assessment of the effects of selective and nonselective COX-2 inhibitors on T-cell-dependent antibody and natural killer cell responses in the rat.

PMID 18958669·J Immunotoxicol·2005

8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address: 340 W EAST AVE
CHICO, CA 95926
Phone: (530) 332-3277

Quick Facts

NPI: 1154578565
Entity Type: Individual
Gender: Male
Medicare: Accepted
Specialties: 3
Locations: 1
Years in Practice: 18
Publications: 20

Are you this provider?

Claim Your Profile